Literature DB >> 29057540

Differential actions of AMP kinase on ATP-sensitive K+ currents in ventral tegmental area and substantia nigra zona compacta neurons.

Yan-Na Wu1, Ke-Zhong Shen1, Steven W Johnson1,2.   

Abstract

ATP-sensitive K+ (K-ATP) channels play significant roles in regulating the excitability of dopamine neurons in the substantia nigra zona compacta (SNC). We showed previously that K-ATP channel function is up-regulated by AMP-activated protein kinase (AMPK). This study extended these studies to the neurons adjacent to the SNC in the ventral tegmental area (VTA). Using patch pipettes to record whole-cell currents in slices of rat midbrain, we found that the AMPK activator A769662 increased the amplitude of currents evoked by the K-ATP channel opener diazoxide in presumed dopamine-containing VTA neurons. However, current evoked by diazoxide with A769662 was significantly smaller in VTA neurons compared to SNC neurons. Moreover, a significantly lower proportion of VTA neurons responded to diazoxide with outward current. However, A769662 was able to increase the incidence of diazoxide-responsive neurons in the VTA. In contrast, A769662 did not potentiate diazoxide-evoked currents in presumed non-dopamine VTA neurons. These results show that AMPK activation augments K-ATP currents in presumed dopamine neurons in the VTA and SNC, although diazoxide-evoked currents remain less robust in the VTA. We conclude that K-ATP channels may play important physiological roles in VTA and SNC dopamine neurons.
© 2017 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  AMP kinase; ATP-sensitive potassium channel; diazoxide; dopamine neuron; patch-clamp recording

Mesh:

Substances:

Year:  2017        PMID: 29057540      PMCID: PMC5716849          DOI: 10.1111/ejn.13756

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  41 in total

1.  Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.

Authors:  D C German; K F Manaye; P K Sonsalla; B A Brooks
Journal:  Ann N Y Acad Sci       Date:  1992-05-11       Impact factor: 5.691

2.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

Authors:  A A Grace; B S Bunney
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

Review 3.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

4.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

5.  Leptin regulates KATP channel trafficking in pancreatic β-cells by a signaling mechanism involving AMP-activated protein kinase (AMPK) and cAMP-dependent protein kinase (PKA).

Authors:  Pei-Chun Chen; Yelena N Kryukova; Show-Ling Shyng
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

Review 6.  Predictive reward signal of dopamine neurons.

Authors:  W Schultz
Journal:  J Neurophysiol       Date:  1998-07       Impact factor: 2.714

7.  Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans.

Authors:  D A McRitchie; G M Halliday
Journal:  Neuroscience       Date:  1995-03       Impact factor: 3.590

Review 8.  Reward and aversion in a heterogeneous midbrain dopamine system.

Authors:  Stephan Lammel; Byung Kook Lim; Robert C Malenka
Journal:  Neuropharmacology       Date:  2013-04-08       Impact factor: 5.250

9.  K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration.

Authors:  Julia Schiemann; Falk Schlaudraff; Verena Klose; Markus Bingmer; Susumu Seino; Peter J Magill; Kareem A Zaghloul; Gaby Schneider; Birgit Liss; Jochen Roeper
Journal:  Nat Neurosci       Date:  2012-08-19       Impact factor: 24.884

10.  PKC-dependent human monocyte adhesion requires AMPK and Syk activation.

Authors:  Mei-Ying Chang; Duen-Yi Huang; Feng-Ming Ho; Kuo-Chin Huang; Wan-Wan Lin
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more
  6 in total

1.  Kir6.2 Deficiency Promotes Mesencephalic Neural Precursor Cell Differentiation via Regulating miR-133b/GDNF in a Parkinson's Disease Mouse Model.

Authors:  Yan Zhou; Jialei Zhu; Yang Lv; Chenghuan Song; Jianhua Ding; Ming Xiao; Ming Lu; Gang Hu
Journal:  Mol Neurobiol       Date:  2018-03-21       Impact factor: 5.590

2.  AMP-activated protein kinase slows D2 dopamine autoreceptor desensitization in substantia nigra neurons.

Authors:  Wei Yang; Adam C Munhall; Steven W Johnson
Journal:  Neuropharmacology       Date:  2019-07-10       Impact factor: 5.250

3.  Phosphoinositol metabolism affects AMP kinase-dependent K-ATP currents in rat substantia nigra dopamine neurons.

Authors:  Ke-Zhong Shen; Adam C Munhall; Steven W Johnson
Journal:  Brain Res       Date:  2018-10-26       Impact factor: 3.252

4.  Pituitary Adenylate Cyclase Activating Polypeptide Inhibits A10 Dopamine Neurons and Suppresses the Binge-like Consumption of Palatable Food.

Authors:  Nikki Le; Jennifer Hernandez; Cassandra Gastelum; Lynnea Perez; Isabella Vahrson; Sarah Sayers; Edward J Wagner
Journal:  Neuroscience       Date:  2021-09-28       Impact factor: 3.590

5.  Metformin in nucleus accumbens core reduces cue-induced cocaine seeking in male and female rats.

Authors:  Amy Chan; Alexis Willard; Sarah Mulloy; Noor Ibrahim; Allegra Sciaccotta; Mark Schonfeld; Sade M Spencer
Journal:  Addict Biol       Date:  2022-05       Impact factor: 4.093

6.  Somatostatin-evoked Aβ catabolism in the brain: Mechanistic involvement of α-endosulfine-KATP channel pathway.

Authors:  Naoto Watamura; Naomasa Kakiya; Per Nilsson; Satoshi Tsubuki; Naoko Kamano; Mika Takahashi; Shoko Hashimoto; Hiroki Sasaguri; Takashi Saito; Takaomi C Saido
Journal:  Mol Psychiatry       Date:  2021-11-04       Impact factor: 13.437

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.